Product
SBRT 7Gy
1 clinical trial
1 indication
Indication
NSCLCClinical trial
A Phase Ib Study on Toripalimab Combined With Anlotinib and SBRT for Patients With Untreated Brain Metastases of Driven Gene-negative Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-06-01